Application Nr Approved Date Route Status External Links
ANDA203182 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Cisatracurium Besylate Injection Is An Intermediate-Onset/intermediate-Duration Neuromuscular Blocking Agent Indicated For Inpatients And Outpatients As An Adjunct To General Anesthesia, To Facilitate Tracheal Intubation, And To Provide Skeletal Muscle Relaxation During Surgery Or Mechanical Ventilation In The Icu.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cisatracurium Besylate CISATRACURIUM BESYLATE ZINC96006013

Comments